Three live procedures demonstrated how “state of the art” imaging visualizes the prostate gland more clearly to improve diagnosis and staging. Dr. Duke Bahn showed that when abnormalities are detected, a needle biopsy can be directed specifically to the area, resulting in more precise findings than random biopsy. Tumor size and location can be measured precisely and can be monitored objectively. Dr. Fred Lee stated that the size of cancer is the most potent factor in predicting survival, regardless of Gleason. For more on prostate cancer, see PCRI.org.